Oncology

Eurofins Viracor BioPharma is a unique clinical development partner with proven expertise in custom assay design and validation across a broad array of industry-leading analytical platforms.  We partner with our clients to support their oncology-focused translational research with innovative technologies and integrated testing solutions that provide the flexibility and scalability to help advance their pioneering treatments to market faster.

Molecular & genomics bioassay capabilities for clinical immunotherapy studies:

• Predictive biomarker assays (whole exome or RNA sequencing)
• qPCR or microarray-based RNA expression assays
• Gene expression profiles for detecting and characterizing mutations/biomarkers in cancer cells with Nanostring technology.
• Comprehensive targeted NGS panels or tumor profiling assays to detect known and emerging biomarkers, and measure tumor mutational burden

We also offers a comprehensive and diverse technology portfolio, together with in-house expertise, to provide custom assay design, validation, and analysis for any supported platform including:

• PCR, ddPCR, Sanger
• NGS (WGS, WES, RNASeq, somatic testing, and custom panels
• Nanostring (non-PCR gene  expression)
• Flow Cytometry